I’ll be honest, when I first saw the FTSE 100 cross the 10,000 mark earlier this year, I didn’t just read the headline, I felt it. Not because it’s a…
When I look back at the past year in global pharma, a few stories have grabbed my attention, like Novo Nordisk. Not long ago, it was the darling of the…
I’ve been closely tracking China’s AI semiconductor race, and one development that genuinely caught my attention is Baidu’s plan to spin off its AI chip arm Kunlunxin and pursue a…
When I first saw the announcement about the proposed merger between Devyani International and Sapphire Foods, my immediate reaction was simple: this is not just another corporate restructuring headline; it…
U.S. Treasury yields edged slightly lower on Wednesday as investors stayed cautious ahead of the final economic data release of 2025. The 10-year Treasury yield fell by 1 basis point…
2025 was an unusual year for global markets, breaking the usual patterns after an election year. If 2024 was just the warm-up, 2025 was the main event. The year was…
When I first saw reports that SoftBank Group had officially completed its massive OpenAI funding commitment, my immediate reaction wasn’t shock; it was curiosity. Because this isn’t just another big-ticket…
If there’s one tech‑energy development from 2025 that genuinely made me sit up and reflect on the future of AI + energy infrastructure, Octopus Energy's decision to spin off Kraken…